Journal of Affective Disorders
Volume 110, Issue 1 , Pages 135-141 , September 2008

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study

  • A.C. Altamura

      Affiliations

    • Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy, Via Francesco Sforza 35, Milano. Tel.: +39 02 55035982; fax: +39 02 50320310.
    • ,
  • E. Mundo

      Affiliations

    • Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
    • ,
  • B. Dell'Osso

      Affiliations

    • Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
    • ,
  • G. Tacchini

      Affiliations

    • Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
    • ,
  • M. Buoli

      Affiliations

    • Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy
    • ,
  • J.R. Calabrese

      Affiliations

    • Mood Disorders Program, Department of Psychiatry, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio, USA

Received 5 October 2007 ,Revised 16 January 2008 ,Accepted 16 January 2008.

References 

  1. Altamura AC, Madaro D, Salvadori D. Quetiapine in acute mania a case report with 6 month follow-up. Int. J. Psychiatry Clin. Pract. 2001;5:283–285
  2. Altamura AC, Bassetti R, Fumagalli S. Pharmacotherapy of mixed anxiety/depression disorders. In:  Kasper S,  Den Boer JA,  Sitsen JM editor. Handbook of Depression and Anxiety. New York: Marcel Dekker; 2003;p. 757–778
  3. Altamura AC, Salvadori D, Madaro D, Santini A, Mundo E. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. J. Affect. Disord. 2003;761:267–271
  4. Altamura AC, Russo M, Vismara S, Mundo E. Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder. J. Clin. Psychopharmacol. 2004;24:454–456
  5. Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J. Clin. Psychiatry. 2005;66:111–121
  6. Calabrese JR, Rapport DJ. Mood stabilizers and the evolution of maintenance study designs in Bipolar I disorder. J. Clin. Psychiatry. 1999;60:5–13
  7. Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry. 2005;162:1351–1360
  8. Goldstein JM, Christoph G, Grimm S, Liu JW, Widzowski D, Brecher M. In: Unique Mechanism of Action for the Antidepressant Properties of the Atypical Antipyshcotic Quetiapine. Presented at the 160th Annual Meeting of the American Psychiatric Association, San Diego, California, May 19–24 [poster]. 2007;
  9. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  10. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry. 2002;59:530–537
  11. McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur. Neuropsychopharmacol. 2005;15:573–585
  12. Mundo E, Cattaneo E, Zanoni S, Altamura AC. The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder. Neuropsychiatric. Disease and Treatment. 2006;2:139–148
  13. Rouget BW, Aubry JM. Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature. J. Affect. Disord. 2007;98:11–27
  14. Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004;6:213–223
  15. Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. 2007;9:394–412
  16. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr. Scand. 2007;115:12–20
  17. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry. 2003;160:1263–1271
  18. Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br. J. Psychiatry. 2004;184:337–345
  19. Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am. J. Psychiatry. 2005;162:1281–1290
  20. Vieta E, Calabrese J, Goikolea J, Raines S, Macfadden W for the BOLDER Study Group. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2007;9:413–425
  21. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for Mania: reliability, validity and sensitivity. Br. J. Psychiatry. 1978;133:429–435

☆ The Authors thank Alessandro Gavarini, MD, Filippo Castellano, MD, and Marzia Giansante, MD, for their contribution in data collection and database management.

PII: S0165-0327(08)00039-6

doi: 10.1016/j.jad.2008.01.017

Journal of Affective Disorders
Volume 110, Issue 1 , Pages 135-141 , September 2008

Article Tools

* Image Usage & Resolution